Valuation: Amoéba

Market Cap 50.29M 58.11M 46.97M 43.08M 81.04M 5.53B 82.24M 551M 216M 2.77B 218M 213M 9.18B P/E 2026 *
-9.73x
P/E 2027 * 73x
Enterprise Value 61.44M 71M 57.38M 52.63M 99.01M 6.76B 100M 673M 264M 3.38B 266M 261M 11.21B EV / Sales 2026 *
12x
EV / Sales 2027 * 4x
Free-Float
87.09%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 60 14/12/2023
Chief Tech/Sci/R&D Officer - 01/09/2018
Corporate Officer/Principal - 01/03/2022
Director TitleAgeSince
Director/Board Member - 01/06/2014
Chairman 70 14/12/2023
Director/Board Member 70 25/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 58.13M
+0.49%-2.72%-14.78%-24.00% 3.28B
+1.19%+7.07%+10.05%-3.15% 2.21B
-1.27%+1.88%-21.30%-35.97% 1.81B
-1.47%-11.38%+14.83%-0.07% 1.67B
+0.04%-0.62%-23.85% - 1.5B
+0.48%-2.15%-15.22%-43.34% 1.41B
+0.22%-1.40%-27.80%+35.01% 1.34B
-0.67%-2.32%-6.18%-17.03% 1.32B
+3.84%+24.22%-27.93%+86.96% 1.17B
Average +0.28%+1.78%-12.47%-0.20% 1.75B
Weighted average by Cap. +0.26%+0.99%-11.16%-6.02%

Financials

2026 *2027 *
Net sales 5.1M 5.89M 4.76M 4.37M 8.22M 561M 8.34M 55.85M 21.9M 281M 22.12M 21.64M 931M 15.55M 17.97M 14.52M 13.32M 25.06M 1.71B 25.43M 170M 66.77M 856M 67.44M 65.98M 2.84B
Net income -5.2M -6.01M -4.86M -4.45M -8.38M -572M -8.5M -56.94M -22.33M -286M -22.55M -22.07M -949M 550K 636K 514K 471K 886K 60.51M 899K 6.02M 2.36M 30.29M 2.39M 2.33M 100M
Net Debt 11.15M 12.88M 10.41M 9.55M 17.97M 1.23B 18.23M 122M 47.88M 614M 48.36M 47.31M 2.03B 11.85M 13.69M 11.07M 10.15M 19.1M 1.3B 19.38M 130M 50.88M 653M 51.4M 50.28M 2.16B
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
23
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7300EUR
Average target price
1.400EUR
Spread / Average Target
+91.78%

Annual profits - Rate of surprise